Company Filing History:
3 out of 108 
1 out of 41 Years Active: 2010-2016
Introduction
Piere-Etienne Chabrier De Lassauniere is an innovative inventor based in Paris, France, known for his groundbreaking contributions to the field of pain management. With a total of three patents to his name, he has made significant strides in utilizing botulinum neurotoxin for therapeutic purposes.
Latest Patents
Among his notable patents, the latest focuses on the therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy. The invention outlines a method of preparing the neurotoxin for local administration that avoids the central nervous system (CNS), effectively treating pain at a site distant from where the administration occurs. This innovation could greatly enhance the quality of life for individuals suffering from this condition.
Career Highlights
Throughout his career, Piere-Etienne has worked with reputable companies in the pharmaceutical industry, including Ipsen Pharma S.A.S. and Ipsen Biopharm Limited. His experience in these organizations has fostered a rich understanding of therapeutic development and innovation.
Collaborations
In his pursuit of innovation, Piere-Etienne has collaborated with distinguished professionals such as Christine Favre and Michel Auguet. These collaborations have propelled his research forward, contributing to the advancement of medical treatments involving botulinum neurotoxin.
Conclusion
Piere-Etienne Chabrier De Lassauniere stands as a prominent figure in the realm of medical innovation, particularly in the treatment of nerve-related pain. His patents reflect a commitment to improving patient outcomes and exemplify the vital role of inventors in the advancement of healthcare solutions.